SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001193125-10-020702
Filing Date
2010-02-03
Accepted
2010-02-03 15:30:37
Documents
7

Document Format Files

Seq Description Document Type Size
1 REVISED PRELIMINARY PROXY STATEMENT dprer14a.htm PRER14A 2226410
3 GRAPHIC g86301g10m59.jpg GRAPHIC 2778
4 GRAPHIC g86301g48y93.jpg GRAPHIC 9335
5 GRAPHIC g86301g67p72.jpg GRAPHIC 11651
6 GRAPHIC g86301g84k77.jpg GRAPHIC 12847
7 GRAPHIC g86301g88s00.jpg GRAPHIC 10161
8 filename8.htm CORRESP 12960
  Complete submission text file 0001193125-10-020702.txt   2306245
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
Type: PRER14A | Act: 34 | File No.: 000-04829 | Film No.: 10570482
SIC: 2836 Biological Products, (No Diagnostic Substances)